FDAFDA · Food and drugs·Recall number D-1149-2023
Sucralfate Oral Suspension 1g per 10mL, FOR ORAL ADMINISTRATION ONLY (414 mL bottle), Rx Only, Manufactured and Distributed by: VistaPharm, Inc. Largo, FL 33771, NDC 66689-305-16
Published September 20, 2023 · Recall initiated: August 30, 2023
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Superpotent/Subpotent single ingredient Drug: Out of Specification Assay results
What to do
Voluntary: Firm initiated · Letter
Recall details
- Brand
- SUCRALFATE
- Manufacturer
- VistaPharm LLC
- Distributor
- Distributed nationwide to 68 consignees in the U.S.
- UPC
- 0366689305165
- Lot
- Lot #: 921100; Exp. 02/2025
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.